15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35124372 | TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1. | 2022 Mar | 4 |
2 | 35179655 | METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. | 2022 Feb 18 | 4 |
3 | 33495407 | Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. | 2021 Jan 20 | 5 |
4 | 34497808 | PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway. | 2021 | 10 |
5 | 31907114 | Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway. | 2019 Dec 1 | 1 |
6 | 30400960 | MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma. | 2018 Nov 6 | 2 |
7 | 25767076 | Oxaliplatin triggers necrosis as well as apoptosis in gastric cancer SGC-7901 cells. | 2015 May 1 | 6 |
8 | 25976336 | Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo. | 2015 | 1 |
9 | 26543375 | Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer. | 2015 | 1 |
10 | 24215868 | Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells. | 2014 Feb 28 | 1 |
11 | 23355248 | [Influence of oxaliplatin combined with LCP on proliferation and apoptosis of colon cancer cell line HT29]. | 2013 Jan | 1 |
12 | 22528234 | Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin. | 2012 Apr | 1 |
13 | 20550106 | Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1. | 2010 Jul 27 | 1 |
14 | 12008204 | Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death. | 2002 May | 1 |
15 | 11593056 | Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo. | 2001 Oct | 1 |